Institut de Cancerologie des Hospices Civils de Lyon

Pierre-Bénite, Lyon 69310

0 studies enrolling now · 1 studies all time

What they study most

Ovarian Cancer

Studies at this site

• ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3) — Running, not enrolling